title: Outcome of involved-field radiotherapy for stage 1 follicular lymphoma.
authors.forename: Naoto
authors.initials: N
authors.lastname: Tomita
authors.forename: Fumio
authors.initials: F
authors.lastname: Kodama
authors.forename: Kenji
authors.initials: K
authors.lastname: Motohashi
authors.forename: Atsuko
authors.initials: A
authors.lastname: Fujita
authors.forename: Rie
authors.initials: R
authors.lastname: Hyo
authors.forename: Chizuko
authors.initials: C
authors.lastname: Hashimoto
authors.forename: Sachiya
authors.initials: S
authors.lastname: Takemura
authors.forename: Etsuko
authors.initials: E
authors.lastname: Yamazaki
authors.forename: Jun
authors.initials: J
authors.lastname: Taguchi
authors.forename: Rika
authors.initials: R
authors.lastname: Sakai
authors.forename: Shin
authors.initials: S
authors.lastname: Fujisawa
authors.forename: Heiwa
authors.initials: H
authors.lastname: Kanamori
authors.forename: Shigeki
authors.initials: S
authors.lastname: Motomura
authors.forename: Yoshiaki
authors.initials: Y
authors.lastname: Ishigatsubo
authors.forename: Kengo
authors.initials: K
authors.lastname: Takeuchi
mesh_terms: D000368:Aged; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008224:Lymphoma, Follicular / Q000401:mortality / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D011879:Radiotherapy Dosage; D012074:Remission Induction; D012189:Retrospective Studies; D015996:Survival Rate; D016896:Treatment Outcome